373 related articles for article (PubMed ID: 21781293)
1. Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.
Ceribelli A; Krzyszczak ME; Li Y; Ross SJ; Chan JY; Chan EK; Burlingame RW; Webb TT; Bubb MR; Sobel ES; Reeves WH; Satoh M
Arthritis Res Ther; 2011 Jul; 13(4):R119. PubMed ID: 21781293
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma.
Satoh M; Vazquez-Del Mercado M; Krzyszczak ME; Li Y; Ceribelli A; Burlingame RW; Webb TT; Sobel ES; Reeves WH; Chan EK
Lupus; 2012 Jan; 21(1):68-74. PubMed ID: 22025191
[TBL] [Abstract][Full Text] [Related]
3. Nucleolar staining cannot be used as a screening test for the scleroderma marker anti-RNA polymerase I/III antibodies.
Yamasaki Y; Honkanen-Scott M; Hernandez L; Ikeda K; Barker T; Bubb MR; Narain S; Richards HB; Chan EK; Reeves WH; Satoh M
Arthritis Rheum; 2006 Sep; 54(9):3051-6. PubMed ID: 16948135
[TBL] [Abstract][Full Text] [Related]
4. Analysis of autoantibodies against RNA polymerases using immunoaffinity-purifed RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay.
Chang M; Wang RJ; Yangco DT; Sharp GC; Komatireddy GR; Hoffman RW
Clin Immunol Immunopathol; 1998 Oct; 89(1):71-8. PubMed ID: 9756726
[TBL] [Abstract][Full Text] [Related]
5. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay.
Kuwana M; Kimura K; Kawakami Y
Arthritis Rheum; 2002 Oct; 46(10):2742-7. PubMed ID: 12384934
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.
Santiago M; Baron M; Hudson M; Burlingame RW; Fritzler MJ
J Rheumatol; 2007 Jul; 34(7):1528-34. PubMed ID: 17610318
[TBL] [Abstract][Full Text] [Related]
7. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
Faucher B; Stein P; Granel B; Weiller PJ; Disdier P; Serratrice J; Harlé JR; Durand JM; Frances Y; Guis S; Pham T; Bardin N; Sanmarco M
Eur J Intern Med; 2010 Apr; 21(2):114-7. PubMed ID: 20206882
[TBL] [Abstract][Full Text] [Related]
8. Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
Moinzadeh P; Fonseca C; Hellmich M; Shah AA; Chighizola C; Denton CP; Ong VH
Arthritis Res Ther; 2014 Feb; 16(1):R53. PubMed ID: 24524733
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.
Nikpour M; Hissaria P; Byron J; Sahhar J; Micallef M; Paspaliaris W; Roddy J; Nash P; Sturgess A; Proudman S; Stevens W
Arthritis Res Ther; 2011; 13(6):R211. PubMed ID: 22189167
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis.
Villalta D; Morozzi G; Tampoia M; Alpini C; Brusca I; Salgarolo V; Papisch W; Bizzaro N
Clin Chim Acta; 2010 May; 411(9-10):710-3. PubMed ID: 20138166
[TBL] [Abstract][Full Text] [Related]
11. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis.
Kuwana M; Okano Y; Pandey JP; Silver RM; Fertig N; Medsger TA
Arthritis Rheum; 2005 Aug; 52(8):2425-32. PubMed ID: 16052583
[TBL] [Abstract][Full Text] [Related]
13. Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients.
Liu C; Hou Y; Xu D; Li L; Zhang Y; Cheng L; Yan S; Zhang F; Li Y
Clin Rheumatol; 2020 Apr; 39(4):1191-1197. PubMed ID: 31858335
[TBL] [Abstract][Full Text] [Related]
14. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
Harvey GR; Butts S; Rands AL; Patel Y; McHugh NJ
Clin Exp Immunol; 1999 Aug; 117(2):395-402. PubMed ID: 10444276
[TBL] [Abstract][Full Text] [Related]
15. A case of renal crisis in a Korean scleroderma patient with anti-RNA polymerase I and III antibodies.
Kang EH; Im CH; Kim SH; Chung JR; Lee EY; Kim DJ; Lee EB; Song YW
J Korean Med Sci; 2006 Dec; 21(6):1121-3. PubMed ID: 17179700
[TBL] [Abstract][Full Text] [Related]
16. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
18. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.
Hamaguchi Y; Kodera M; Matsushita T; Hasegawa M; Inaba Y; Usuda T; Kuwana M; Takehara K; Fujimoto M
Arthritis Rheumatol; 2015 Apr; 67(4):1045-52. PubMed ID: 25512203
[TBL] [Abstract][Full Text] [Related]
19. Serologic profile and mortality rates of scleroderma renal crisis in Italy.
Codullo V; Cavazzana I; Bonino C; Alpini C; Cavagna L; Cozzi F; Del Papa N; Franceschini F; Guiducci S; Morozzi G; Ruffatti A; Ferri C; Giacomelli R; Matucci-Cerinic M; Valentini G; Montecucco C
J Rheumatol; 2009 Jul; 36(7):1464-9. PubMed ID: 19487262
[TBL] [Abstract][Full Text] [Related]
20. HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities.
Kuwana M; Pandey JP; Silver RM; Kawakami Y; Kaburaki J
J Rheumatol; 2003 Nov; 30(11):2392-7. PubMed ID: 14677183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
